IN SB0150

Caps out-of-pocket costs for a 30-day supply of prescription insulin at $35, regardless of the number of prescriptions or types of insulin filled during that period

Applies to health insurance plans issued, delivered, amended, or renewed after June 30, 2026

Defines "prescription insulin drug" as any insulin-containing prescription drug used to treat diabetes that has been prescribed as medically necessary

Permits insurers to set the cap lower than $35 at their discretion

Exempts high deductible health plans from the cap requirement if compliance would disqualify them under Section 223 of the Internal Revenue Code